BackCerus Overview
Cerus Corp.

Cerus Target Price

Where could CERS trade next? Consensus target price: $4.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.19

Average Target Price

$4.0082.6% upside

1 analysts in the last 4 months

High: $4 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-01BTIG$482.6% upsideOpen
2024-10-17Stifel NicolausMathew Blackman$337% upsideOpen
2024-05-03Cantor FitzgeraldBrandon Folkes$482.6% upsideOpen
2024-04-12Craig-HallumBill Bonello$5128.3% upsideOpen

Cerus (CERS) FAQ

As of the most recent data, CERS shows a target price of $4. Scroll down for historical charts and peer comparison views.

If Cerus moved to the average analyst target of $4, shares would be roughly 82.6% higher than $2.19. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Cerus's earnings trajectory.

Besides this target price page, Stockcircle has Cerus's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $4) with ownership activity and broader fundamentals.

Cerus's target price is $4; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.